{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:27:18Z","timestamp":1774682838735,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jiac.2022.01.018","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T15:47:31Z","timestamp":1644076051000},"page":"823-827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hemophagocytic syndrome due to Epstein-Barr virus and cytomegalovirus coinfection in a patient on adalimumab"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8146-1359","authenticated-orcid":false,"given":"Moe","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7225-2819","authenticated-orcid":false,"given":"Tetsuji","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Tagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jiac.2022.01.018_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/infdis\/132.5.546","article-title":"A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody","volume":"132","author":"Evans","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2022.01.018_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220184","article-title":"Massive splenomegaly due to concurrent primary Epstein-Barr virus and cytomegalovirus infection in a patient on adalimumab","volume":"2017","author":"Ramasamy","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.jiac.2022.01.018_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12985-017-0715-7","article-title":"Epstein-Barr virus and cytomegalovirus infections and their clinical relevance in Egyptian leukemic pediatric patients","volume":"14","author":"Loutfy","year":"2017","journal-title":"Virol J"},{"issue":"3","key":"10.1016\/j.jiac.2022.01.018_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<186::AID-JMV2>3.0.CO;2-3","article-title":"Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection","volume":"56","author":"Aalto","year":"1998","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.jiac.2022.01.018_bib5","article-title":"Coinfection rates and clinical outcome data for cytomegalovirus and Epstein-Barr virus in post-transplant patients: a systematic review of the literature","volume":"22","author":"Anderson-Smits","year":"2020","journal-title":"Transpl Infect Dis Off J Transplant Soc"},{"issue":"1","key":"10.1016\/j.jiac.2022.01.018_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/07853890500465189","article-title":"Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives","volume":"38","author":"Verbsky","year":"2006","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.jiac.2022.01.018_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1651-2227.1991.tb11878.x","article-title":"Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr Scand"},{"issue":"4","key":"10.1016\/j.jiac.2022.01.018_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.semarthrit.2015.07.004","article-title":"Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies","volume":"45","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"18","key":"10.1016\/j.jiac.2022.01.018_bib9","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.3748\/wjg.14.2912","article-title":"Cytomegalovirus colitis in a patient with Behcet's disease receiving tumor necrosis factor alpha inhibitory treatment","volume":"14","author":"Sari","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jiac.2022.01.018_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1874312900903010030","article-title":"Epstein-barr virus (EBV) prevalence and the risk of reactivation in patients with inflammatory arthritis using anti-TNF agents and in those who are biologic naive","volume":"3","author":"McKeown","year":"2009","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.jiac.2022.01.018_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1743-422X-7-247","article-title":"Coinfection with EBV\/CMV and other respiratory agents in children with suspected infectious mononucleosis","volume":"7","author":"Wang","year":"2010","journal-title":"Virol J"},{"issue":"11","key":"10.1016\/j.jiac.2022.01.018_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27929","article-title":"Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American consortium for histiocytosis (NACHO)","volume":"66","author":"Jordan","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.jiac.2022.01.018_bib13","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","article-title":"Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages","volume":"105","author":"Billiau","year":"2005","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.jiac.2022.01.018_bib14","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2012-10-463166","article-title":"The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2","volume":"121","author":"Jessen","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jiac.2022.01.018_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MPG.0b013e31816a30b9","article-title":"Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab","volume":"47","author":"Francolla","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.jiac.2022.01.018_bib16","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and Cochrane overview","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.jiac.2022.01.018_bib17","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1172\/JCI119728","article-title":"Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome","volume":"100","author":"Lay","year":"1997","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.jiac.2022.01.018_bib18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1172\/JCI116995","article-title":"The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression","volume":"93","author":"Geist","year":"1994","journal-title":"J Clin Invest"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22000344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22000344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:03:49Z","timestamp":1761159829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22000344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1341321X22000344"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.01.018","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemophagocytic syndrome due to Epstein-Barr virus and cytomegalovirus coinfection in a patient on adalimumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}